Literature DB >> 35533802

The recent outbreak of acute severe hepatitis in children of unknown origin - what is known so far.

Marcus Maximilian Mücke1, Stefan Zeuzem2.   

Abstract

At the beginning of April 2022, 10 cases of severe acute hepatitis of unknown origin in children <10 years of age were reported across central Scotland. Since then, case numbers have increased rapidly, with 191 probable cases identified across Europe, the United States of America, Israel and Japan. Until now, 17 children required liver transplantation and 1 died. Accordingly, the Centers for Disease Control and Prevention and the European Centre for Diseases Prevention and Control have both issued a warning on a hepatitis of unknown origin in children. This review focuses on the available information concerning this recent outbreak and introduces some of the potential explanations for its development.
Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35533802     DOI: 10.1016/j.jhep.2022.05.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   30.083


  11 in total

Review 1.  Acute hepatitis (Non Hepa A-E) of unknown origin among pediatrics.

Authors:  Nasim Asadi Faezi; Bahareh Mehramouz; Sepehr Taghizadeh; Pasquale Pagliano; Hossein Samadi Kafil
Journal:  Infez Med       Date:  2022-09-01

2.  Mysterious cases of acute hepatitis in children: is adenovirus still a lead suspect?

Authors:  Adriana E Kajon; Kirsten St George
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

Review 3.  Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak.

Authors:  Li-Ya Zhang; Li-Su Huang; Yu-Hang Yue; Rima Fawaz; Joseph K Lim; Jian-Gao Fan
Journal:  J Clin Transl Hepatol       Date:  2022-06-22

4.  Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022.

Authors:  Ruben H de Kleine; Willem S Lexmond; Gustav Buescher; Ekkehard Sturm; Deidre Kelly; Ansgar W Lohse; Dominic Lenz; Marianne Hørby Jørgensen
Journal:  Euro Surveill       Date:  2022-05

Review 5.  Hepatitis of Unknown Origin and Etiology (Acute Non HepA-E Hepatitis) among Children in 2021/2022: Review of the Current Findings.

Authors:  Malik Sallam; Azmi Mahafzah; Gülşen Özkaya Şahin
Journal:  Healthcare (Basel)       Date:  2022-05-24

Review 6.  Suspected Adenovirus Causing an Emerging HEPATITIS among Children below 10 Years: A Review.

Authors:  Ali A Rabaan; Muhammed A Bakhrebah; Majed S Nassar; Zuhair S Natto; Abbas Al Mutair; Saad Alhumaid; Mohammed Aljeldah; Mohammed Garout; Wadha A Alfouzan; Fatimah S Alshahrani; Tarek Sulaiman; Meshal K AlFonaisan; Mubarak Alfaresi; Saleh A Alshamrani; Firzan Nainu; Shin Jie Yong; Om Prakash Choudhary; Naveed Ahmed
Journal:  Pathogens       Date:  2022-06-21

7.  Acute Liver Failure and Acute-on-Chronic Liver Failure in COVID-19 Era.

Authors:  Tatsuo Kanda; Reina Sasaki-Tanaka; Tomotaka Ishii; Hayato Abe; Masahiro Ogawa; Hirayuki Enomoto
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

Review 8.  Acute hepatitis of unknown origin in Europe-Adding fuel to already burning pandemic.

Authors:  Maliha Tahir; Sejal Lund; Amatul Hadi Hamdana; Shahzaib Ahmad; Muhammad Umar; Shahzaib Farid; Muhammad Osama Siddiqui; Muhammad Muneeb Khawar
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

Review 9.  Severe acute hepatitis of unknown causes in children - Current findings, questions, opinions, and recommendations, a mini-review.

Authors:  Getu Zhaori
Journal:  Pediatr Investig       Date:  2022-07-11

10.  Immunological characteristics of severe acute hepatitis of unknown origin in a child post SARS-CoV-2 infection.

Authors:  Atsushi Morita; Kazuo Imagawa; Kei Asayama; Tsubasa Terakado; Shoko Takahashi; Katsuyuki Yaita; Manabu Tagawa; Daisuke Matsubara; Hidetoshi Takada
Journal:  Clin Immunol       Date:  2022-09-29       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.